Shuji Toda

7.4k citations
144 papers · 5.6k indexed · 2 hit papers · h-index 38

Shuji Toda

143 papers receiving 5.5k citations

Hit Papers

Sustained in vitro intestinal epithelial culture within a...6842006202620122019200400600

Peers

Shuji Toda
Comparison fields: 5 of 129
  • Immunology and Allergy 319
  • Dermatology 456
  • Oncology 1.3k
  • Genetics 448
  • Physiology 1.1k
Replace George Bou–Gharios with:
George Bou–Gharios United Kingdom
Mark C. Horowitz United States
Jiurong Liang United States
Franck Verrecchia France
Dianhua Jiang United States
Marie‐Luce Bochaton‐Piallat Switzerland
Ian A. Darby Australia
Alain Colige Belgium
Philippe Saas France
Uffe Birk Jensen Denmark
Shuji Toda relative to George Bou–Gharios United Kingdom George Bou–Gharios's profile →
Citations per field
00.5×1.5×2.3×
George Bou–Gharios · 1×
Citations per year

Countries citing papers authored by Shuji Toda

Since Specialization
Citations

This map shows the geographic impact of Shuji Toda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuji Toda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuji Toda more than expected).

Fields of papers citing papers by Shuji Toda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuji Toda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuji Toda. The network helps show where Shuji Toda may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shuji Toda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shuji Toda Line = papers co-authored together Shuji Toda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20232
2 201947
3 20189
4 20186
5 201421
6 20137
7 20127
8 2012139
9 201128
10 201017
11 200631
12 20054
13 200413
14 200159
15 200129
16 199917
17 199932
18 199741
19 199728
20 19881

About Shuji Toda

Shuji Toda is a scholar working on Dermatology, Rehabilitation and Genetics, having authored 144 papers that have together received 5.6k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (18 papers), Cancer and Skin Lesions (13 papers), Tissue Engineering and Regenerative Medicine (11 papers), Wound Healing and Treatments (11 papers), Adipose Tissue and Metabolism (9 papers), Mesenchymal stem cell research (9 papers), Adipokines, Inflammation, and Metabolic Diseases (8 papers) and Animal Genetics and Reproduction (8 papers). The work is most often cited by research in Immunology and Allergy (319 citations), Dermatology (456 citations) and Oncology (1.3k citations). Shuji Toda has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hajime Sugihara, Shigehisa Aoki, Akifumi Ootani, Nobuhisa Yonemitsu, Kenji Izuhara, Kazuhiko Arima, Kazuyoshi Uchihashi, Shinichi Miyabara, Yutaka NARISAWA and Kazuma Fujimoto. Their work appears in journals such as Journal of Clinical Investigation, Nature Medicine and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026